Skip to content
Esta página está disponible en españolCambiar →

SEC filings · updated every 10 minutes

At the SEC on Tuesday, November 10

Tuesday, November 10, 2026 · 226 filings · latest: 21:47 ET

From the companies the site's managers follow: those held by 300+ 13F filers, or 30+ with concentrated managers or well-known investors. Form 144 notices from $1M and insider purchases from $100,000.

Companies with the most concentrated managers that filed that day

Filings of the day

226 filings from 213 companies

  • HF Sinclair

    DINO
    • 21:47 ET5%+ stakesSEC Schedule 13D/A

      Change in a 5%+ stake with activist intent

      REH Advisors reports a 2.7% stake (4,431,662 shares), below 5% as of October 29, 2026.

      Filed by: REH Advisors Inc.

    On GestorLens

    • 4 concentrated managers
    • 450 13F filers
    • 2 insiders bought in 180 days ($3.5M)
    • 1 13D filings in the last year

    Well-known investors: Semper Augustus

    GestorLens profile
  • Wolfspeed

    WOLF
    • 19:57 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      the Goldman Sachs Group and 1 related filer updated their stake: 5.3% (2,810,829 shares) (passive, 13G) as of September 30, 2026.

      Filed by: GOLDMAN SACHS GROUP INC

    On GestorLens

    • 1 concentrated managers (+1 this quarter)
    • 86 13F filers

    Well-known investors: Dan Loeb

    GestorLens profile
  • UWM Holdings

    UWMC
    • 19:53 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      the Goldman Sachs Group and 1 related filer report a 2.6% stake (9,081,465 shares), below 5% as of September 30, 2026.

      Filed by: GOLDMAN SACHS GROUP INC

    On GestorLens

    • 133 13F filers
    • 1 13D filings in the last year

    Well-known investors: Stanley Druckenmiller

    GestorLens profile
  • Liberty Global

    LBTYK
    • 19:42 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      the Goldman Sachs Group and 1 related filer reported a stake: 6.3% (11,214,077 shares) (passive, 13G) as of September 30, 2026.

      Filed by: GOLDMAN SACHS GROUP INC

    On GestorLens

    • 1 concentrated managers
    • 128 13F filers

    Well-known investors: Seth Klarman

    GestorLens profile
  • IREN

    IREN
    • 19:35 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      the Goldman Sachs Group and 1 related filer updated their stake: 7.2% (28,444,392 shares) (passive, 13G) as of September 30, 2026.

      Filed by: GOLDMAN SACHS GROUP INC

    On GestorLens

    • 3 concentrated managers
    • 332 13F filers

    Well-known investors: Stanley Druckenmiller

    GestorLens profile
  • Black Stone Minerals

    BSM
    • 17:16 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Thomas L Carter Jr (Executive Chairman) bought 50,000 shares for $686,290 (avg. $13.73).

    On GestorLens

    • 3 concentrated managers
    • 116 13F filers
    • 2 insiders bought in 180 days ($2.2M)
    GestorLens profile
  • nVent Electric

    NVT
    • 17:16 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Herbert K Parker (director) bought 3,000 shares for $339,435 (avg. $113.15).

    On GestorLens

    • 2 concentrated managers
    • 515 13F filers
    GestorLens profile
  • Illumina

    ILMN
    • 17:15 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Corvex Management may sell up to 375,000 shares (~$82.8 million, 0.25% of shares outstanding) on or about November 10, 2026.

    On GestorLens

    • 3 concentrated managers
    • 622 13F filers
    GestorLens profile
  • Graco

    GGG
    • 17:13 ETDividends and buybacksSEC 8-K 8.01

      Share buyback

      New share buyback of up to 15,000,000 shares.

      Company headline: “Graco Announces $600 Million Accelerated Share Repurchase Agreement”

      Also: Regulation FD disclosure

      From the filing
      In December 2025, the Company's Board of Directors (the "Board") authorized the Company's repurchase of up to an aggregate of 15 million shares of Common Stock, which was in addition to the approximately 8 million shares of Common Stock remaining under the share repurchase authorization approved by the Board in December 2018.

    On GestorLens

    • 8 concentrated managers (+1 this quarter)
    • 383 13F filers
    GestorLens profile
  • Textron

    TXT
    • 17:12 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      Invesco reported a stake: 5.1% (8,853,800 shares) (passive, 13G) as of September 30, 2026.

      Filed by: Invesco Ltd.

    On GestorLens

    • 406 13F filers
    GestorLens profile
  • Centrus Energy

    LEU2 filings
    • 17:04 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Kevin M. Graney joins the board.

      From the filing
      On November 4, 2026, the Board of Directors (the “Board”) of Centrus Energy Corp. (the “Company”) increased its size from seven directors to eight directors and appointed Kevin M. Graney to the Board effective immediately.
    • 06:50 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street and 1 related filer reported a stake: 7.4% (1,468,760 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 4 concentrated managers (+1 this quarter)
    • 191 13F filers
    GestorLens profile
  • Neurocrine Biosciences

    NBIX
    • 16:47 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Sanjay Keswani may sell up to 53,614 shares (~$9.0 million, 0.05% of shares outstanding) on or about November 10, 2026.

    On GestorLens

    • 5 concentrated managers (+2 this quarter)
    • 401 13F filers
    GestorLens profile
  • Monolithic Power Systems

    MPWR
    • 16:47 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Invesco reports a 4.8% stake (2,354,421 shares), below 5% as of September 30, 2026.

      Filed by: Invesco Ltd.

    On GestorLens

    • 6 concentrated managers (+1 this quarter)
    • 702 13F filers
    GestorLens profile
  • MKS

    MKSI
    • 16:46 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Invesco reports a 3.5% stake (2,382,533 shares), below 5% as of September 30, 2026.

      Filed by: Invesco Ltd.

    On GestorLens

    • 3 concentrated managers
    • 331 13F filers
    GestorLens profile
  • Vivmark Residential

    VMRK
    • 16:44 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Barry Altshuler (officer) may sell up to 49,808 shares (~$3.3 million) on or about November 10, 2026.

    On GestorLens

    • 4 concentrated managers
    • 500 13F filers
    GestorLens profile
  • Manhattan Associates

    MANH
    • 16:42 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      Invesco reported a stake: 5.7% (3,325,462 shares) (passive, 13G) as of September 30, 2026.

      Filed by: Invesco Ltd.

    On GestorLens

    • 2 concentrated managers
    • 284 13F filers

    Well-known investors: Terry Smith

    GestorLens profile
  • FedEx

    FDX
    • 16:38 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Claude F Russ (officer) may sell up to 16,762 shares (~$5.3 million) on or about November 10, 2026.

    On GestorLens

    • 9 concentrated managers
    • 1,155 13F filers

    Well-known investors: Gates Foundation Trust, Viking Global

    GestorLens profile
  • Motorola Solutions

    MSI
    • 16:38 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Gregory Q Brown (officer, director) may sell up to 25,000 shares (~$13.2 million) on or about November 10, 2026.

    On GestorLens

    • 6 concentrated managers (+1 this quarter)
    • 867 13F filers
    GestorLens profile
  • Paychex

    PAYX
    • 16:33 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: B Thomas Golisano (10% holder) may sell up to 439,970 shares (~$51 million, 0.12% of shares outstanding) on or about November 9, 2026.

    On GestorLens

    • 15 concentrated managers
    • 963 13F filers

    Well-known investors: Markel Group, Semper Augustus

    GestorLens profile
  • Carvana

    CVNA
    • 16:32 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: James Danforth Quayle (director) may sell up to 27,655 shares (~$2.0 million) on or about November 10, 2026.

    On GestorLens

    • 3 concentrated managers (+1 this quarter)
    • 404 13F filers
    • 1 insider bought in 180 days ($2,207)
    • 1 13D filings in the last year

    Well-known investors: Lone Pine, Viking Global, Coatue, Stanley Druckenmiller

    GestorLens profile
  • FirstService

    FSV
    • 16:32 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Fred Reichheld (director) may sell up to 7,200 shares (~$1.1 million) on or about November 10, 2026.

    On GestorLens

    • 4 concentrated managers
    • 107 13F filers
    GestorLens profile
  • Alcon

    ALC
    • 16:31 ETEarningsSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “Innovation and Product Launch Momentum Drive Alcon’s Third-Quarter 2026 Growth”

      From the company's release
      "We remain on track for our 2026 objectives with year-to-date sales growth of six percent and double-digit core EPS growth, despite some specific areas of competitive pressure.” said David J. Endicott, Alcon’s Chief Executive Officer.

    On GestorLens

    • 7 concentrated managers (+1 this quarter)
    • 313 13F filers
    GestorLens profile
  • Elevance Health

    ELV
    • 16:30 ETOtherSEC 8-K 7.01

      Regulation FD disclosure

      From the filing
      Officers of Elevance Health, Inc. (the “Company”) expect to speak with investors and analysts this week. During these meetings, Company officers will reaffirm the Company’s shareholders’ earnings guidance for full year 2026 to be at least $22.00 per diluted share, including approximately $7.00 per diluted share of net unfavorable items.

    On GestorLens

    • 14 concentrated managers (-3 this quarter)
    • 941 13F filers
    • 2 insiders bought in 180 days ($1.4M)

    Well-known investors: Seth Klarman

    GestorLens profile
  • Align Technology

    ALGN
    • 16:30 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      G. Zachary Gund, as trustee, sole manager or co-manager and 5 related filers report a 2.5% stake (1,783,647 shares), below 5% as of September 30, 2026.

      Filed by: Gund G Zachary

    On GestorLens

    • 3 concentrated managers
    • 317 13F filers
    GestorLens profile
  • Neptune Insurance Holdings

    NP
    • 16:29 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Matthew Duffy (officer, director) may sell up to 86,000 shares (~$2.4 million, 0.09% of shares outstanding) on or about November 10, 2026.

    On GestorLens

    • 36 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • Hinge Health

    HNGE
    • 16:27 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: James Budge (officer) may sell up to 35,907 shares (~$4.4 million, 0.05% of shares outstanding) on or about November 10, 2026.

    On GestorLens

    • 3 concentrated managers (+2 this quarter)
    • 143 13F filers
    GestorLens profile
  • Palantir Technologies

    PLTR
    • 16:26 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Shyam Sankar (officer) may sell up to 300,000 shares (~$50.8 million) on or about November 10, 2026.

    On GestorLens

    • 23 concentrated managers (+3 this quarter)
    • 2,069 13F filers
    GestorLens profile
  • Everpure

    P3 filings
    • 16:26 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Charles Giancarlo (director, officer) may sell up to 70,000 shares (~$7.2 million) on or about November 10, 2026.

    • 16:24 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: the RWC Trust U/a DTD 02/08/2011 (director, officer) may sell up to 50,000 shares (~$5.1 million) on or about November 10, 2026.

    • 16:24 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: the Eec Trust U/a DTD 02/08/2011 (director, officer) may sell up to 50,000 shares (~$5.1 million) on or about November 10, 2026.

    On GestorLens

    • 3 concentrated managers
    • 505 13F filers
    GestorLens profile
  • Tapestry

    TPR2 filings
    • 16:25 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Scott A. Roe (officer) may sell up to 117,875 shares (~$16 million, 0.06% of shares outstanding) on or about November 10, 2026.

    • 09:21 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 5.1% (10,213,254 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 1 concentrated managers
    • 562 13F filers
    GestorLens profile
  • Assurant

    AIZ2 filings
    • 16:25 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: the Biju Nair Declaration of Trust (officer) may sell up to 9,818 shares (~$3.1 million) on or about November 10, 2026.

    • 16:24 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Ryan T Lumsden (officer) may sell up to 3,901 shares (~$1.2 million) on or about November 10, 2026.

    On GestorLens

    • 1 concentrated managers (+1 this quarter)
    • 321 13F filers
    GestorLens profile
  • L3harris Technologies

    LHX2 filings
    • 16:24 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Christopher Kubasik (officer) may sell up to 20,000 shares (~$5.5 million) on or about November 10, 2026.

    • 08:30 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 5% (9,343,754 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 11 concentrated managers
    • 972 13F filers
    GestorLens profile
  • Akamai Technologies

    AKAM
    • 16:23 ETOtherSEC 8-K 8.01

      Other events

      Company headline: “Akamai Announces Pricing of Offering of Convertible Senior Notes”

      From the company's release
      Akamai Technologies, Inc. (Nasdaq: AKAM) (“Akamai”), today announced that it has priced its private offering of $1.1 billion in aggregate principal amount of 1.00% convertible senior notes due 2028 (the “2028 Notes”) and $1.1 billion in aggregate principal amount of 1.00% convertible senior notes due 2031 (the “2031 Notes” and, together with the 2028 Notes, the “notes”).

    On GestorLens

    • 4 concentrated managers
    • 394 13F filers
    GestorLens profile
  • Hagerty

    HGTY
    • 16:22 ETOtherSEC 8-K 7.01

      Regulation FD disclosure

      Company headline: “Secondary Offering of its Class A Common Stock”

      From the company's release
      Hagerty will not receive any proceeds from the sale of shares of its Class A Common Stock by the Selling Stockholder. The Selling Stockholder will bear the underwriting discount attributable to its sale of the Class A Common Stock, and Hagerty will bear the remaining expenses.

    On GestorLens

    • 50 13F filers
    • 1 insider bought in 180 days ($99,370)
    • 2 13D filings in the last year

    Well-known investors: Markel Group

    GestorLens profile
  • T. Rowe Price

    TROW
    • 16:21 ETOtherSEC 8-K 8.01

      Other events

      From the filing
      At its meeting on November 4, 2026, T. Rowe Price Group, Inc.'s (the "Company") Executive Compensation and Management Development Committee (the "Committee") amended the T. Rowe Price Group, Inc. 2020 Long-Term Incentive Plan (the “Plan”) along with the form of the Notice of Grant under the Plan (the "Notice").

    On GestorLens

    • 5 concentrated managers
    • 714 13F filers

    Well-known investors: Markel Group

    GestorLens profile
  • Arch Capital Group

    ACGL
    • 16:21 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Maamoun Rajeh (officer) may sell up to 48,661 shares (~$5.3 million) on or about November 10, 2026.

    On GestorLens

    • 5 concentrated managers
    • 495 13F filers
    GestorLens profile
  • GoPro

    GPRO
    • 16:19 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      From the filing
      On November 10, 2026, GoPro, Inc. (the “Company”) filed with the Securities and Exchange Commission a Notification of Late Filing on Form 12b-25 (the “Form 12b-25”) with respect to its Quarterly Report on Form 10-Q for the quarter ended September 30, 2026.

    On GestorLens

    • 64 13F filers
    • 1 13D filings in the last year

    Well-known investors: David Einhorn

    GestorLens profile
  • HawkEye 360

    HAWK
    • 16:19 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Company headline: “HawkEye 360 Appoints Former CIA Director Ambassador William J. Burns to Board of Directors”

      Also: Regulation FD disclosure

      From the filing
      On November 10, 2026, the Board of Directors (the “Board”) of HawkEye 360, Inc. (the “Company”) appointed Ambassador William J. Burns as a Board member, effective immediately.

    On GestorLens

    • 37 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • Genpact

    G
    • 16:18 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Piyush Mehta (officer) may sell up to 200,000 shares (~$8.6 million, 0.12% of shares outstanding) on or about November 10, 2026.

    On GestorLens

    • 4 concentrated managers (+1 this quarter)
    • 246 13F filers
    GestorLens profile
  • WEC Energy Group

    WEC
    • 16:18 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Margaret C Kelsey (officer) may sell up to 18,380 shares (~$2.2 million) on or about November 10, 2026.

    On GestorLens

    • 4 concentrated managers (-1 this quarter)
    • 790 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • Factset Research Systems

    FDS
    • 16:18 ETOtherSEC 8-K 7.01

      Regulation FD disclosure

      Company headline: “FactSet Hosts Investor Day 2026”

      From the company's release
      “FactSet has a generational opportunity to become the world’s most trusted financial intelligence platform and create long-term shareholder value.

    On GestorLens

    • 4 concentrated managers (-2 this quarter)
    • 452 13F filers

    Well-known investors: Markel Group

    GestorLens profile
  • Keel Infrastructure

    KEEL
    • 16:17 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      From the filing
      Effective November 4, 2026, Rachel Silverstein ceased serving as EVP, General Counsel and Corporate Secretary of Keel Infrastructure Corp. (the “Company”). We appreciate Ms. Silverstein’s contributions to the success of the Company during her tenure.

    On GestorLens

    • 126 13F filers
    • 2 insiders bought in 180 days ($525,657)

    Well-known investors: Soros Fund

    GestorLens profile
  • Dollar General

    DG
    • 16:17 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Timothy I. McGuire resigns from the board.

      From the filing
      On November 5, 2026, Timothy I. McGuire notified Dollar General Corporation (the “Company”) of his decision to resign from the Company’s Board of Directors for personal reasons.

    On GestorLens

    • 6 concentrated managers
    • 684 13F filers

    Well-known investors: Markel Group, Semper Augustus

    GestorLens profile
  • Invesco

    IVZ

    On GestorLens

    • 1 concentrated managers
    • 370 13F filers

    Well-known investors: Nelson Peltz

    GestorLens profile
  • Costco Wholesale

    COST
    • 16:16 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Helena B. Foulkes resigns from the board, effective November 7, 2026.

      Company headline: “COSTCO WHOLESALE CORPORATION DECLARES $30 SPECIAL CASH DIVIDEND AND REAUTHORIZES STOCK REPURCHASE PROGRAM”

      Also: Other events

      From the filing
      On November 7, 2026, Helena B. Foulkes notified the Board of Directors (the “Board”) of Costco Wholesale Corporation (the “Company”) of her decision to resign from the Board and all committees of the Board of which she is a member, effective November 7, 2026.

    On GestorLens

    • 48 concentrated managers (-2 this quarter)
    • 2,814 13F filers

    Well-known investors: Markel Group, Semper Augustus

    GestorLens profile
  • Core & Main

    CNM
    • 16:16 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Company headline: “Core & Main Announces Preliminary Third-Quarter Fiscal 2026 Results, Updated Fiscal 2026 Outlook, Multiple Acquisitions and Record Share Repurchases”

      From the company's release
      In the third quarter, Core & Main delivered 3% sales growth amid a mixed demand environment. Preliminary Adjusted EBITDA (Non-GAAP) was affected by higher transportation costs and investments in greenfields to drive long-term growth.

    On GestorLens

    • 1 concentrated managers
    • 196 13F filers
    • 1 insider bought in 180 days ($95,103)

    Well-known investors: Soros Fund

    GestorLens profile
  • Ventas

    VTR
    • 16:15 ETOtherSEC 8-K 8.01

      Other events

      From the filing
      On November 10, 2026, Ventas Realty, Limited Partnership (“Ventas Realty”), a wholly owned subsidiary of Ventas, Inc. (the “Company”), issued and sold $500,000,000 in aggregate principal amount of its 5.500% Senior Notes due 2033 (the “Notes”) in a registered public offering pursuant to the existing registration statement of the Company and Ventas Realty on Form S-3 (File Nos. 333-277185 and 333-277185-01) filed…

    On GestorLens

    • 3 concentrated managers
    • 530 13F filers
    • 1 insider bought in 180 days ($197,025)
    GestorLens profile
  • Steris

    STE
    • 16:15 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Mohsen Sohi (director) may sell up to 4,893 shares (~$1.2 million) on or about November 10, 2026.

    On GestorLens

    • 5 concentrated managers (-1 this quarter)
    • 429 13F filers
    GestorLens profile
  • American Barrick Gold Corp

    • 16:14 ETIPOsSEC S-1

      IPO registration filing

      Underwriters: Goldman Sachs, BofA Securities, Citigroup, RBC Capital Markets

    Not listed yet: no profile.

  • Visa

    V
    • 16:12 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Paul D Fabara (officer) may sell up to 3,401 shares (~$1.4 million) on or about November 10, 2026.

    On GestorLens

    • 86 concentrated managers (+2 this quarter)
    • 2,992 13F filers

    Well-known investors: Markel Group, Chris Hohn, ValueAct, Akre Capital and 4 more

    GestorLens profile
  • AAON

    AAON
    • 16:11 ETDividends and buybacksSEC 8-K 8.01

      Dividends and buybacks

      Other events.

      Company headline: “The Aaon Group Announces Quarterly Cash Dividend”

      From the company's release
      AAON, Inc. (NASDAQ: AAON), doing business as The Aaon Group, a leader in high-performing, energy-efficient HVAC solutions that bring long-term value to customers and owners, today announced that its Board of Directors has declared the Company’s next regular quarterly cash dividend of $0.10 per share (or $0.40 annually), payable on December 17, 2026…

    On GestorLens

    • 1 concentrated managers (-1 this quarter)
    • 207 13F filers
    • 2 insiders bought in 180 days ($109,584)

    Well-known investors: Giverny Capital

    GestorLens profile
  • eBay

    EBAY
    • 16:10 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Julie Anne Loeger (officer) may sell up to 41,649 shares (~$5.1 million) on or about November 10, 2026.

    On GestorLens

    • 6 concentrated managers (-1 this quarter)
    • 723 13F filers
    • 1 13D filings in the last year
    GestorLens profile
  • Chevron

    CVX
    • 16:10 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Mark A Nelson (officer) may sell up to 112,000 shares (~$23.6 million) on or about November 10, 2026.

    On GestorLens

    • 45 concentrated managers (-1 this quarter)
    • 2,881 13F filers

    Well-known investors: Berkshire Hathaway, Semper Augustus

    GestorLens profile
  • Lumentum Holdings

    LITE3 filings
    • 16:07 ETMergers and tender offersSEC 425

      Communication about a merger or acquisition

      Marvell Technology filed a communication about its deal with Lumentum Holdings.

      From the filing
      On November 2, 2026, Matt Murphy, CEO of Marvell Technology, Inc. (“Marvell”), and Michael Hurlston, CEO of Lumentum Holdings Inc. (“Lumentum”), participated in an interview on “Fox Business: The Claman Countdown.”
    • 16:05 ETMergers and tender offersSEC 425

      Communication about a merger or acquisition

      Marvell Technology filed a communication about its deal with Lumentum Holdings.

      From the filing
      On November 2, 2026, Matt Murphy, CEO of Marvell Technology, Inc. (“Marvell”), and Michael Hurlston, CEO of Lumentum Holdings Inc. (“Lumentum”), participated in an interview on “CNBC; Squawk on the Street.”
    • 16:03 ETMergers and tender offersSEC 425

      Communication about a merger or acquisition

      Marvell Technology filed a communication about its deal with Lumentum Holdings.

      From the filing
      The following communication was made available to employees of Marvell via email by Matt Murphy, Chairman and Chief Executive Officer of Marvell Technology, Inc. (“Marvell”) on November 10, 2026.

    On GestorLens

    • 16 concentrated managers (+2 this quarter)
    • 766 13F filers
    GestorLens profile
  • Capital One Financial

    COF

    On GestorLens

    • 9 concentrated managers
    • 1,241 13F filers

    Well-known investors: Markel Group, Dan Loeb, Soros Fund, Viking Global and 1 more

    GestorLens profile
  • Northern Trust

    NTRS
    • 16:05 ETOtherSEC 8-K 8.01

      Other events

      From the filing
      On November 10, 2026, Northern Trust Corporation (the “Company”) issued $1,000,000,000 of its 5.300% Senior Notes due 2031 (the “2031 Notes”) and $1,000,000,000 of its 5.700% Senior Notes due 2036 (the “2036 Notes” and, together with the 2031 Notes, the “Notes”) pursuant to an underwriting agreement, dated as of November 5, 2026, by and among the Company, BofA Securities, Inc., Citigroup Global Markets Inc.…

    On GestorLens

    • 7 concentrated managers
    • 579 13F filers
    • 1 insider bought in 180 days ($85,691)
    GestorLens profile
  • CoreWeave

    CRWV
    • 16:05 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 (ended September 30, 2026) results.

      Company headline: “CoreWeave Reports Strong Third Quarter 2026 Results”

      From the company's release
      "This was a breakout quarter for CoreWeave, with revenue increasing by more than $1 billion sequentially and adjusted operating margins reaching double digits a quarter ahead of plan," said Michael Intrator, co-founder, chairman and chief executive officer of CoreWeave.

    On GestorLens

    • 3 concentrated managers (+1 this quarter)
    • 544 13F filers

    Well-known investors: David Tepper, Soros Fund

    GestorLens profile
  • Independence Realty Trust

    IRT
    • 16:05 ETOtherSEC 8-K 7.01

      Regulation FD disclosure

      Vote results of the special shareholder meeting held on November 10, 2026.

      Company headline: “Independence Realty Trust Stockholders and Centerspace Shareholders Approve Merger”

      Also: Shareholder vote results

      From the filing
      Independence Realty Trust, Inc. (the "Company") held a special meeting of stockholders on November 10, 2026 (the "Special Meeting").

    On GestorLens

    • 3 concentrated managers
    • 204 13F filers
    GestorLens profile
  • Sea

    SE
    • 16:05 ETEarningsSEC 6-K

      Foreign issuer report

      Q3 2026 (ended September 30, 2026) results.

      Company headline: “Sea Limited Reports Third Quarter 2026 Results”

      From the company's release
      In the third quarter of 2026, Sea’s GAAP revenue was US$8.6 billion, up 43.4% year-on-year. The Company also achieved gross profit of US$3.9 billion, up 51.4% year-on-year, and net income of US$502.5 million, up 34.0% year-on-year.

    On GestorLens

    • 9 concentrated managers (+2 this quarter)
    • 377 13F filers
    • 1 13D filings in the last year

    Well-known investors: Tiger Global, Stanley Druckenmiller, Howard Marks, Viking Global and 1 more

    GestorLens profile
  • Cavco Industries

    CVCO
    • 16:04 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Brian Cira (officer) may sell up to 2,382 shares (~$1.6 million) on or about November 10, 2026.

    On GestorLens

    • 171 13F filers

    Well-known investors: Stanley Druckenmiller

    GestorLens profile
  • Molina Healthcare

    MOH
    • 16:03 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Jeff D Barlow (officer) may sell up to 8,000 shares (~$1.6 million) on or about November 10, 2026.

    On GestorLens

    • 2 concentrated managers (-1 this quarter)
    • 301 13F filers

    Well-known investors: Michael Burry, Seth Klarman

    GestorLens profile
  • Danaher

    DHR
    • 16:03 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Georgeann Couchara may sell up to 23,010 shares (~$5.4 million) on or about November 10, 2026.

    On GestorLens

    • 22 concentrated managers (-1 this quarter)
    • 1,300 13F filers

    Well-known investors: Dan Loeb, Tiger Global, Stanley Druckenmiller, Gates Foundation Trust

    GestorLens profile
  • Eastman Chemical

    EMN
    • 16:03 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Julie A. McAlindon (SVP, Regions & Chf SupChn Ofcr) bought 2,451 shares for $159,989 (avg. $65.27).

    On GestorLens

    • 1 concentrated managers
    • 360 13F filers

    Well-known investors: Markel Group

    GestorLens profile
  • HCA Healthcare

    HCA
    • 16:02 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Erica Rossitto (officer) may sell up to 3,500 shares (~$1.8 million) on or about November 10, 2026.

    On GestorLens

    • 8 concentrated managers
    • 771 13F filers
    • 1 13D filings in the last year

    Well-known investors: Markel Group

    GestorLens profile
  • Hess Midstream

    HESM
    • 15:51 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Invesco updated its stake: 6.5% (8,345,361 shares) (passive, 13G) as of September 30, 2026.

      Filed by: Invesco Ltd.

    On GestorLens

    • 3 concentrated managers
    • 117 13F filers
    • 1 13D filings in the last year
    GestorLens profile
  • Globe Life

    GL
    • 15:46 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Invesco updated its stake: 6.5% (5,020,088 shares) (passive, 13G) as of September 30, 2026.

      Filed by: Invesco Ltd.

    On GestorLens

    • 3 concentrated managers
    • 365 13F filers
    GestorLens profile
  • Element Solutions

    ESI
    • 15:38 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Invesco reports a 1.6% stake (4,015,209 shares), below 5% as of September 30, 2026.

      Filed by: Invesco Ltd.

    On GestorLens

    • 3 concentrated managers
    • 233 13F filers
    • 1 13D filings in the last year
    GestorLens profile
  • MetLife

    MET
    • 15:34 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Michel Khalaf (officer, director) may sell up to 187,425 shares (~$19.1 million) on or about November 10, 2026.

    On GestorLens

    • 1 concentrated managers
    • 910 13F filers
    • 1 13D filings in the last year
    GestorLens profile
  • United Airlines Holdings

    UAL
    • 15:17 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: J Scott Kirby (officer, director) may sell up to 90,367 shares (~$10.9 million) on or about November 10, 2026.

    On GestorLens

    • 2 concentrated managers (-1 this quarter)
    • 546 13F filers

    Well-known investors: Stanley Druckenmiller

    GestorLens profile
  • Cognizant Technology Solutions

    CTSH
    • 15:16 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Invesco reports a 3.2% stake (14,622,570 shares), below 5% as of September 30, 2026.

      Filed by: Invesco Ltd.

    On GestorLens

    • 4 concentrated managers
    • 530 13F filers
    • 1 insider bought in 180 days ($209,768)

    Well-known investors: Semper Augustus

    GestorLens profile
  • Cognex

    CGNX
    • 15:12 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      Invesco reported a stake: 5.1% (8,517,786 shares) (passive, 13G) as of September 30, 2026.

      Filed by: Invesco Ltd.

    On GestorLens

    • 4 concentrated managers
    • 350 13F filers
    GestorLens profile
  • Globus Medical

    GMED
    • 15:11 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: James R Tobin (director) may sell up to 41,666 shares (~$3.1 million) on or about November 10, 2026.

    On GestorLens

    • 4 concentrated managers (+1 this quarter)
    • 329 13F filers
    GestorLens profile
  • The Clorox

    CLX
    • 15:08 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      Invesco reported a stake: 5.2% (6,294,677 shares) (passive, 13G) as of September 30, 2026.

      Filed by: Invesco Ltd.

    On GestorLens

    • 4 concentrated managers (+1 this quarter)
    • 580 13F filers
    • 1 insider bought in 180 days ($400,251)

    Well-known investors: Terry Smith

    GestorLens profile
  • Credicorp

    BAP
    • 15:05 ETEarningsSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “Analysis of 3Q26 Consolidated Results”

      From the company's release
      Credicorp Ltd. Reports Financial and Operating Results for 3Q26 3Q26 ROE of 19.9%, supported by loan growth, healthy asset quality and diversified revenues; FY26 guidance of ~19.5% and the medium-term expectation of ~22% reaffirmed.

    On GestorLens

    • 8 concentrated managers
    • 201 13F filers
    GestorLens profile
  • Charles River Laboratories International

    CRL
    • 15:03 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Invesco reports a 3.9% stake (1,852,539 shares), below 5% as of September 30, 2026.

      Filed by: Invesco Ltd.

    On GestorLens

    • 3 concentrated managers (+1 this quarter)
    • 313 13F filers
    GestorLens profile
  • Allstate

    ALL
    • 14:45 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Thomas J Wilson (officer, director) may sell up to 130,917 shares (~$34 million, 0.05% of shares outstanding) on or about November 10, 2026.

    On GestorLens

    • 2 concentrated managers
    • 1,083 13F filers

    Well-known investors: Markel Group

    GestorLens profile
  • Acadian Asset Management

    AAMI
    • 14:34 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      Invesco reported a stake: 5.6% (1,989,483 shares) (passive, 13G) as of September 30, 2026.

      Filed by: Invesco Ltd.

    On GestorLens

    • 138 13F filers
    • 1 13D filings in the last year

    Well-known investors: Soros Fund

    GestorLens profile
  • Steel Dynamics

    STLD
    • 14:12 ETDividends and buybacksSEC 8-K 8.01

      Dividend announcement

      Quarterly dividend of $0.53 per share, payable January 8, 2027 to shareholders of record on December 31, 2026.

      Company headline: “Steel Dynamics Announces Additional $3.0 Billion Share Repurchase Authorization and Fourth Quarter 2026 Cash Dividend”

      From the company's release
      The company's board of directors also declared a quarterly cash dividend of $0.53 per common share. The dividend is payable to shareholders of record at the close of business on December 31, 2026, and is payable on or about January 8, 2027.

    On GestorLens

    • 3 concentrated managers
    • 594 13F filers
    GestorLens profile
  • Willis Towers Watson

    WTW
    • 14:06 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      First Eagle Investment Management reported a stake: 5% (4,689,660 shares) (passive, 13G) as of September 30, 2026.

      Filed by: First Eagle Investment Management, LLC

    On GestorLens

    • 2 concentrated managers (-1 this quarter)
    • 373 13F filers
    GestorLens profile
  • Floor & Decor Holdings

    FND
    • 13:07 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Ersan Sayman (officer) may sell up to 21,428 shares (~$1.1 million) on or about November 10, 2026.

    On GestorLens

    • 2 concentrated managers (-1 this quarter)
    • 211 13F filers

    Well-known investors: Giverny Capital

    GestorLens profile
  • Reinsurance Group of America

    RGA
    • 13:05 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Jonathan Porter (officer) may sell up to 3,852 shares (~$1.0 million) on or about November 10, 2026.

    On GestorLens

    • 2 concentrated managers (-1 this quarter)
    • 350 13F filers
    GestorLens profile
  • Broadridge Financial Solutions

    BR2 filings
    • 12:53 ETDividends and buybacksSEC 8-K 8.01

      Dividend announcement

      Quarterly dividend of $1.09 per share, payable January 11, 2027 to shareholders of record on December 10, 2026.

      Company headline: “Broadridge Declares Quarterly Dividend of $1.09 Per Share”

      Also: Amendments to bylaws or fiscal year

      From the filing
      On November 10, 2026, Broadridge Financial Solutions, Inc. (the "Company") issued a press release announcing that its Board of Directors has declared a quarterly cash dividend of $1.09 per share. The dividend is payable on January 11, 2027 to stockholders of record at the close of business on December 10, 2026.
    • 06:46 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 5.1% (5,766,233 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 5 concentrated managers (+2 this quarter)
    • 605 13F filers
    GestorLens profile
  • BlackRock

    BLK
    • 12:04 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Rachel Lord (officer) may sell up to 7,000 shares (~$8.5 million) on or about November 9, 2026.

    On GestorLens

    • 12 concentrated managers (+1 this quarter)
    • 1,524 13F filers

    Well-known investors: Markel Group, ValueAct

    GestorLens profile
  • Church & Dwight

    CHD
    • 10:45 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Surabhi Pokhriyal (officer) may sell up to 21,970 shares (~$2.4 million) on or about November 10, 2026.

    On GestorLens

    • 5 concentrated managers
    • 594 13F filers

    Well-known investors: Terry Smith

    GestorLens profile
  • KLA

    KLAC
    • 10:09 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Richard P Wallace (officer, director) may sell up to 72,014 shares (~$10.7 million) on or about November 10, 2026.

    On GestorLens

    • 12 concentrated managers (+1 this quarter)
    • 1,406 13F filers
    GestorLens profile
  • Trimble

    TRMB
    • 09:24 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4% stake (9,301,634 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 3 concentrated managers
    • 374 13F filers
    GestorLens profile
  • TKO Group Holdings

    TKO
    • 09:21 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 5% (3,667,379 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 4 concentrated managers
    • 306 13F filers
    • 1 insider bought in 180 days ($987,797)
    • 1 13D filings in the last year

    Well-known investors: Soros Fund

    GestorLens profile
  • Skyworks Solutions

    SWKS
    • 09:16 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.6% stake (6,855,096 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 393 13F filers
    GestorLens profile
  • RPM International

    RPM
    • 09:12 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.6% stake (5,836,328 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 1 concentrated managers
    • 391 13F filers
    GestorLens profile
  • Reddit

    RDDT
    • 09:08 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 6.4% (9,324,459 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 3 concentrated managers
    • 474 13F filers
    • 1 13D filings in the last year

    Well-known investors: Tiger Global, Coatue, Viking Global, Stanley Druckenmiller and 1 more

    GestorLens profile
  • Quest Diagnostics

    DGX
    • 09:06 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 5% (5,563,421 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 4 concentrated managers
    • 663 13F filers
    GestorLens profile
  • Icon

    ICLR
    • 09:03 ETOtherSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “ICON to Participate at Upcoming Investor Conferences”

      From the company's release
      ICON plc (NASDAQ: ICLR), a world-leading clinical research organization, today announced that Mr. Barry Balfe, CEO of ICON plc, and Mr. Nigel Clerkin, CFO of ICON plc, will present at the Jefferies Global Healthcare Conference in London on Tuesday, November 17, 2026 at 12:30pm GMT and Mr. Barry Balfe, CEO of ICON plc, will participate at the 9th Annual Evercore Healthcare Conference on Tuesday, December 1…

    On GestorLens

    • 4 concentrated managers (-1 this quarter)
    • 183 13F filers
    GestorLens profile
  • Qualcomm

    QCOM
    • 09:01 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      Filed by: STATE STREET CORP

    On GestorLens

    • 20 concentrated managers (+1 this quarter)
    • 1,925 13F filers

    Well-known investors: Viking Global, David Tepper, Coatue

    GestorLens profile
  • Allison Transmission Holdings

    ALSN

    On GestorLens

    • 6 concentrated managers
    • 305 13F filers
    GestorLens profile
  • Prudential Financial

    PRU
    • 09:00 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      Filed by: STATE STREET CORP

    On GestorLens

    • 1 concentrated managers (-1 this quarter)
    • 885 13F filers
    GestorLens profile
  • Veradermics

    MANE
    • 08:54 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 results.

      Company headline: “Veradermics Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress”

      From the company's release
      Among participants in the VDPHL01 continued group who received VDPHL01 8.5 mg twice (BID) or once (QD) daily for twelve months, participants achieved a mean increase in non-vellus target area hair count (TAHC) of 43.9 hairs/cm² (BID) and 29.7 hairs/cm² (QD) at Month 12.

    On GestorLens

    • 5 concentrated managers
    • 164 13F filers
    • 4 13D filings in the last year

    Well-known investors: Viking Global

    GestorLens profile
  • Oneok

    OKE
    • 08:53 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 6.6% (41,513,057 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 22 concentrated managers
    • 1,662 13F filers
    GestorLens profile
  • Omnicom Group

    OMC
    • 08:52 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 7.4% (20,353,572 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 5 concentrated managers (-1 this quarter)
    • 1,103 13F filers
    GestorLens profile
  • Oceaneering International

    OII
    • 08:51 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.8% stake (4,795,888 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 2 concentrated managers (-3 this quarter)
    • 377 13F filers
    GestorLens profile
  • Novavax

    NVAX
    • 08:50 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 5.4% (8,827,707 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 3 concentrated managers (+1 this quarter)
    • 267 13F filers
    • 1 13D filings in the last year

    Well-known investors: Coatue

    GestorLens profile
  • News

    NWSA
    • 08:49 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 7.2% (26,047,836 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 8 concentrated managers
    • 636 13F filers

    Well-known investors: Starboard Value

    GestorLens profile
  • Netscout Systems

    NTCT
    • 08:48 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.9% stake (3,563,952 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 316 13F filers
    GestorLens profile
  • Nektar Therapeutics

    NKTR
    • 08:44 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 5.2% (1,772,302 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 12 concentrated managers (+2 this quarter)
    • 241 13F filers
    GestorLens profile
  • Mosaic

    MOS
    • 08:43 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 6.2% (19,698,380 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 12 concentrated managers (+3 this quarter)
    • 669 13F filers
    GestorLens profile
  • Medtronic

    MDT
    • 08:41 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 5.2% (66,055,969 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 36 concentrated managers
    • 2,141 13F filers
    GestorLens profile
  • Bitdeer Technologies Group

    BTDR
    • 08:38 ETEarningsSEC 6-K

      Foreign issuer report

      Q3 2026 (ended September 30, 2026) results.

      Company headline: “Bitdeer Reports Unaudited Third Quarter 2026 Results: Record Revenue of US$320.7 Million; Adjusted EBITDA Up 173% to US$69.6 Million AI Cloud revenue backlog grows…”

      From the company's release
      US$30.1 million, including a non-cash loss of US$54.6 million from the change in fair value of the digital assets loan.

    On GestorLens

    • 10 concentrated managers (+6 this quarter)
    • 237 13F filers
    • 2 insiders bought in 180 days ($447,000)
    • 2 13D filings in the last year

    Well-known investors: Stanley Druckenmiller, Lone Pine

    GestorLens profile
  • McEwen

    MUX
    • 08:38 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 5.4% (3,293,188 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 3 concentrated managers
    • 170 13F filers
    • 1 insider bought in 180 days ($18,360)
    GestorLens profile
  • Materion

    MTRN
    • 08:37 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street and 1 related filer reported a stake: 7.7% (1,603,883 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 5 concentrated managers (+2 this quarter)
    • 404 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • Martin Marietta Materials

    MLM
    • 08:34 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.6% stake (3,275,168 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 26 concentrated managers (+1 this quarter)
    • 1,076 13F filers
    • 1 13D filings in the last year

    Well-known investors: Chris Hohn

    GestorLens profile
  • MannKind

    MNKD
    • 08:33 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.7% stake (15,096,712 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 4 concentrated managers
    • 259 13F filers
    GestorLens profile
  • Magnolia Oil & Gas

    MGY
    • 08:33 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.7% stake (12,677,038 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 2 concentrated managers
    • 412 13F filers
    • 3 insiders bought in 180 days ($326,956)
    GestorLens profile
  • Lexeo Therapeutics

    LXEO
    • 08:31 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.4% stake (3,594,095 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 7 concentrated managers (-1 this quarter)
    • 141 13F filers
    GestorLens profile
  • FLEX

    FLEX
    • 08:30 ETOtherSEC 8-K 7.01

      Regulation FD disclosure

      From the company's release
      O U R C O M M I T M E N T Safety First Our success starts with protecting our people. A safe workplace enables our people to thrive, our operations to perform, and a brighter future for our customers, communities and the planet.

    On GestorLens

    • 13 concentrated managers (+6 this quarter)
    • 1,126 13F filers

    Well-known investors: Dan Loeb

    GestorLens profile
  • Kratos Defense & Security Solutions

    KTOS
    • 08:29 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 5.2% (9,707,708 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 4 concentrated managers (-1 this quarter)
    • 633 13F filers
    GestorLens profile
  • Karman Holdings

    KRMN
    • 08:27 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 6% (7,889,482 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 2 concentrated managers
    • 361 13F filers
    • 3 insiders bought in 180 days ($1M)
    GestorLens profile
  • Nova

    NVMI
    • 08:26 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Rani (Raanan) Cohen (director) may sell up to 3,121 shares (~$1.0 million) on or about November 10, 2026.

    On GestorLens

    • 4 concentrated managers
    • 347 13F filers
    GestorLens profile
  • LCI Industries

    LCII3 filings
    • 08:23 ETMergers and tender offersSEC 425

      Communication about a merger or acquisition

      LCI Industries filed a communication about its merger.

      From the filing
      On November 10, 2026, Johnny Sirpilla, the Interim Chief Executive Officer of LCI Industries (the “Company”), sent the following message to all of the Company’s employees via email in connection with the proposed transaction between the Company and Patrick Industries, Inc. (“Patrick”):
    • 07:34 ETMergers and tender offersSEC 425

      Communication about a merger or acquisition

    • 07:32 ETOtherSEC 8-K 8.01

      Other events

      Company headline: “LCI Board Determines that Revised, Unsolicited, Non-Binding Proposal from Monomoy Capital”

      From the company's release
      LCI Industries Reiterates Support for Merger with Patrick ELKHART, Ind. - LCI Industries (NYSE: LCII) (“LCI”) today announced that its Board of Directors (the “Board”), in consultation with its outside financial and legal advisors, has unanimously determined that a revised, unsolicited…

    On GestorLens

    • 360 13F filers
    GestorLens profile
  • Iovance Biotherapeutics

    IOVA
    • 08:22 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.8% stake (21,695,003 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 8 concentrated managers
    • 292 13F filers
    GestorLens profile
  • Intuitive Machines

    LUNR
    • 08:21 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports 5% (8,656,543 shares), 5% or less as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 1 concentrated managers (+1 this quarter)
    • 325 13F filers
    • 1 13D filings in the last year
    GestorLens profile
  • International Paper

    IP
    • 08:20 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 6.5% (34,166,190 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 9 concentrated managers
    • 859 13F filers
    GestorLens profile
  • Intellia Therapeutics

    NTLA
    • 08:19 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 5.6% (7,809,060 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 6 concentrated managers (+3 this quarter)
    • 328 13F filers
    GestorLens profile
  • Indie Semiconductor

    INDI
    • 08:14 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 5.9% (12,902,835 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 3 concentrated managers (+1 this quarter)
    • 219 13F filers
    GestorLens profile
  • Corbus Pharmaceuticals Holdings

    CRBP
    • 08:08 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Company headline: “Corbus Pharmaceuticals Reports Q3 2026 Financial Results and Provides a Corporate Update…”

      Also: Regulation FD disclosure

      From the company's release
      The Company reported a net loss of approximately $37.8 million, or a net loss per basic and diluted share of $1.81, for the three months ended September 30, 2026, compared to a net loss of approximately $23.3 million, or a net loss per basic and diluted share of $1.90, for the three months ended September 30, 2025.

    On GestorLens

    • 4 concentrated managers (+1 this quarter)
    • 107 13F filers
    • 1 insider bought in 180 days ($126,243)
    GestorLens profile
  • Coursera

    COUR
    • 08:06 ETOtherSEC 8-K 2.05

      Exit or restructuring costs

      Restructuring plan: about 10% workforce reduction; estimated costs of $14 million to $17 million.

      From the filing
      The workforce reduction plan is expected to result in the termination of approximately 10% of the Company's global workforce.

    On GestorLens

    • 3 concentrated managers (-1 this quarter)
    • 251 13F filers
    • 1 13D filings in the last year
    GestorLens profile
  • Sigma Lithium

    SGML
    • 08:05 ETOtherSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “SIGMA LITHIUM TO RELEASE 3Q 26 EARNINGS RESULTS ON NOVEMBER 13; WATCH CEO ANA CABRAL ON SIGMA’S NEW CHAPTER OF GROWTH”

      From the company's release
      The Company will hold a conference call to discuss its third quarter 2026 earnings results shortly after, on Friday, November 13, 2026, at 7:00 a.m. EST. Access to the call will be available via webcast.

    On GestorLens

    • 3 concentrated managers (+2 this quarter)
    • 118 13F filers
    GestorLens profile
  • Tyra Biosciences

    TYRA
    • 08:03 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 results.

      Company headline: “Tyra Biosciences Reports Third Quarter 2026 Financial Results and Recent Highlights”

      From the company's release
      Dr. Harris continued, “With a strengthened balance sheet following our $400 million financing, TYRA is entering its next phase of growth from a position of strength.

    On GestorLens

    • 10 concentrated managers (-3 this quarter)
    • 168 13F filers
    • 1 insider bought in 180 days ($20,001)
    • 1 13D filings in the last year
    GestorLens profile
  • Coya Therapeutics

    COYA
    • 08:02 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Results for the quarter ended September 30, 2026.

      Company headline: “Coya Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update”

      From the company's release
      As of September 30, 2026, Coya had cash and cash equivalents of $35.8 million, sufficient to fund operations, as currently planned, past the Phase 2/3 ALSTARS topline data readout and into the second half of 2027.

    On GestorLens

    • 3 concentrated managers
    • 54 13F filers

    Well-known investors: David Einhorn

    GestorLens profile
  • Pepgen

    PEPG
    • 08:00 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 results.

      Company headline: “PepGen Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights”

      Also: Regulation FD disclosure; Other events

      From the company's release
      Topline data from the 10 mg/kg dose cohort demonstrated a mean splicing correction of 46.5%, the highest reported to date in a multiple dose study.

    On GestorLens

    • 6 concentrated managers (+2 this quarter)
    • 70 13F filers

    Well-known investors: Viking Global

    GestorLens profile
  • AST Spacemobile

    ASTS
    • 08:00 ETOtherSEC 8-K 7.01

      Regulation FD disclosure

      Company headline: “Rakuten and AST SpaceMobile Establish “Rakuten AST”…”

      From the company's release
      Rakuten Group, Inc. and AST SpaceMobile, Inc. (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by everyday smartphones, agreed to establish Rakuten AST, Inc. on November 6, 2026 (Japan Standard Time)*1.

    On GestorLens

    • 4 concentrated managers (+1 this quarter)
    • 757 13F filers
    • 1 insider bought in 180 days ($619,200)
    • 4 13D filings in the last year
    GestorLens profile
  • PMV Pharmaceuticals

    PMVP
    • 08:00 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 results.

      Company headline: “PMV Pharmaceuticals Reports Third Quarter 2026 Financial Results and Corporate Highlights”

      From the company's release
      “We achieved significant milestones during the third quarter across the organization,” said David Mack, Ph.D., President and Chief Executive Officer of PMV Pharma.

    On GestorLens

    • 4 concentrated managers
    • 63 13F filers
    • 1 13D filings in the last year
    GestorLens profile
  • Highwoods Properties

    HIW
    • 07:58 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 7.1% (7,802,704 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 4 concentrated managers
    • 369 13F filers
    GestorLens profile
  • Hecla Mining

    HL
    • 07:57 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.7% stake (31,604,111 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 2 concentrated managers (+1 this quarter)
    • 588 13F filers
    GestorLens profile
  • Hancock Whitney

    HWC
    • 07:56 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.9% stake (3,955,751 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 2 concentrated managers
    • 396 13F filers
    GestorLens profile
  • Grail

    GRAL
    • 07:49 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.5% stake (2,015,422 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 7 concentrated managers (-1 this quarter)
    • 374 13F filers
    GestorLens profile
  • Glacier Bancorp

    GBCI
    • 07:48 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.8% stake (6,254,871 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 1 concentrated managers
    • 436 13F filers
    • 1 insider bought in 180 days ($105,840)
    GestorLens profile
  • CRH Public

    CRH
    • 07:42 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Richard H Fearon (director) bought 6,000 shares for $569,700 (avg. $94.95).

    On GestorLens

    • 26 concentrated managers (+2 this quarter)
    • 1,028 13F filers
    • 1 insider bought in 180 days ($189,260)

    Well-known investors: Dan Loeb, Stanley Druckenmiller, Soros Fund

    GestorLens profile
  • Kalaris Therapeutics

    KLRS
    • 07:42 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 results.

      Company headline: “Kalaris Reports Third Quarter 2026 Financial Results and Provides Business Update”

      From the company's release
      Cash, Cash Equivalents and Marketable Securities: As of September 30, 2026, Kalaris had cash, cash equivalents and marketable securities of $82.9 million, compared with cash, cash equivalents and marketable securities of $118.0 million as of December 31, 2025.

    On GestorLens

    • 3 concentrated managers
    • 55 13F filers
    • 1 13D filings in the last year
    GestorLens profile
  • Mirum Pharmaceuticals

    MIRM
    • 07:41 ETOtherSEC 8-K 8.01

      Other events

      From the filing
      On November 10, 2026, Mirum Pharmaceuticals, Inc. (the “Company”) announced that the primary endpoint was met in the Phase 3 AZURE-4 study evaluating brelovitug, an investigational fully human monoclonal antibody that binds to hepatitis B surface antigen, for the treatment of chronic hepatitis delta virus (“HDV”).

    On GestorLens

    • 16 concentrated managers (-1 this quarter)
    • 327 13F filers
    • 1 13D filings in the last year
    GestorLens profile
  • MasterCraft Boat Holdings

    MCFT
    • 07:36 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Company headline: “MasterCraft Boat Holdings, Inc. Reports Results for the First Three Months of Its Transition Period”

      From the company's release
      On May 15, 2026, the Company completed the merger with Marine Products (“Marine Products Transaction”). As a result, the Company recognized incremental net sales of $59.3 million within the Recreation and Sport Fishing segment during the first three months of the Transition Period (as defined below) compared to the first three months of fiscal 2026.

    On GestorLens

    • 3 concentrated managers
    • 155 13F filers
    • 3 insiders bought in 180 days ($148,719)
    • 2 13D filings in the last year
    GestorLens profile
  • Entegris

    ENTG
    • 07:31 ETDividends and buybacksSEC 8-K 8.01

      Share buyback

      New share buyback of up to $500 million.

      Company headline: “ENTEGRIS DETAILS GROWTH STRATEGY AND LONG-TERM FINANCIAL MODEL AT 2026 CAPITAL MARKETS DAY”

      Also: Regulation FD disclosure

      From the filing
      On November 8, 2026, the Board of Directors of the Company (the "Board") authorized a share repurchase program under which the Company may repurchase up to $500 million of its outstanding common stock.

    On GestorLens

    • 13 concentrated managers (+4 this quarter)
    • 750 13F filers

    Well-known investors: Stanley Druckenmiller

    GestorLens profile
  • Geron

    GERN
    • 07:31 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports 5% (31,896,515 shares), 5% or less as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 5 concentrated managers (-1 this quarter)
    • 258 13F filers
    GestorLens profile
  • Frontdoor

    FTDR
    • 07:30 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.7% stake (3,229,939 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 3 concentrated managers (+1 this quarter)
    • 388 13F filers
    GestorLens profile
  • Fox

    FOXA2 filings
    • 07:29 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.9% stake (10,723,159 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    • 07:28 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 7.3% (14,739,582 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 7 concentrated managers (+2 this quarter)
    • 748 13F filers
    • 1 insider bought in 180 days ($10.3M)

    Well-known investors: Stanley Druckenmiller

    GestorLens profile
  • Autolus Therapeutics

    AUTL
    • 07:25 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 (ended September 30, 2026) results.

      Also: Regulation FD disclosure

      From the company's release
      Autolus Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates November 10, 2026 at 7:00 AM EST Company reports AUCATZYL® (obecabtagene autoleucel; obe-cel) net product revenue of $41.2 million, an increase of 95% year-over-year; now expects full-year 2026 AUCATZYL net product revenue to be at or exceeding upper end of $150 million from prior guidance Gross margin increased to 57%…

    On GestorLens

    • 5 concentrated managers
    • 83 13F filers
    • 1 13D filings in the last year
    GestorLens profile
  • FMC

    FMC
    • 07:24 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.2% stake (6,489,128 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 2 concentrated managers
    • 412 13F filers
    • 1 13D filings in the last year
    GestorLens profile
  • Commercial Metals

    CMC
    • 07:24 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Company headline: “CMC Announces CFO Retirement and Succession Plan; Appoints Kenji Hashimoto as Deputy CFO”

      Also: Regulation FD disclosure

      From the filing
      On November 6, 2026, Paul J. Lawrence notified Commercial Metals Company (“CMC” or the “Company”) of his decision to retire from the role of the Company’s Senior Vice President and Chief Financial Officer, effective January 15, 2027.

    On GestorLens

    • 1 concentrated managers
    • 524 13F filers
    • 2 insiders bought in 180 days ($604,468)
    GestorLens profile
  • Fidelity National Information Services

    FIS
    • 07:24 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 5.4% (27,828,330 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 10 concentrated managers (-2 this quarter)
    • 864 13F filers
    GestorLens profile
  • FB Financial

    FBK
    • 07:23 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 5.4% (2,679,079 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 4 concentrated managers (-2 this quarter)
    • 295 13F filers
    • 1 insider bought in 180 days ($1.5M)
    • 2 13D filings in the last year
    GestorLens profile
  • Exxon Mobil

    XOM
    • 07:22 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 5.1% (212,943,706 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 71 concentrated managers (-9 this quarter)
    • 3,901 13F filers

    Well-known investors: Semper Augustus

    GestorLens profile
  • Expedia Group

    EXPE
    • 07:21 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 5% (5,745,071 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 11 concentrated managers (-1 this quarter)
    • 1,127 13F filers
    GestorLens profile
  • EPR Properties

    EPR
    • 07:19 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 5.1% (3,870,076 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 1 concentrated managers
    • 492 13F filers
    GestorLens profile
  • EchoStar

    ECHO
    • 07:17 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 5.7% (9,040,863 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 20 concentrated managers (-7 this quarter)
    • 703 13F filers
    • 1 13D filings in the last year

    Well-known investors: Carl Icahn

    GestorLens profile
  • Eastern Bankshares

    EBC
    • 07:17 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.9% stake (11,091,105 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 3 concentrated managers (-2 this quarter)
    • 326 13F filers
    GestorLens profile
  • Eagle Bancorp

    EGBN
    • 07:15 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.9% stake (1,486,413 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 3 concentrated managers (+1 this quarter)
    • 200 13F filers
    GestorLens profile
  • Dupont De Nemours

    DD
    • 07:13 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.6% stake (6,158,254 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 5 concentrated managers (-1 this quarter)
    • 1,086 13F filers
    GestorLens profile
  • Dollar Tree

    DLTR
    • 07:11 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 5.2% (9,753,063 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 5 concentrated managers
    • 868 13F filers
    • 1 13D filings in the last year

    Well-known investors: Semper Augustus

    GestorLens profile
  • Legend Biotech

    LEGN
    • 07:11 ETEarningsSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “Legend Biotech Reports Third Quarter 2026 Results and Recent Highlights”

      From the company's release
      Median overall survival was not reached at the time of analysis, and 69.2% of patients were alive at five years.

    On GestorLens

    • 8 concentrated managers (+1 this quarter)
    • 219 13F filers
    GestorLens profile
  • Scholar Rock Holding

    SRRK
    • 07:10 ETEarningsSEC 8-K 1.01

      Entry into a material agreement

      Q3 2026 results: loss per share of $0.81.

      Company headline: “Scholar Rock Reports Third Quarter 2026 Financial Results and Recent Business Highlights”

      Also: Results of operations and financial condition; Regulation FD disclosure

      From the company's release
      Net loss per common share was $0.81 for the quarter ended September 30, 2026, compared to $0.90 per common share for the quarter ended September 30, 2025.

    On GestorLens

    • 10 concentrated managers (-1 this quarter)
    • 308 13F filers
    • 1 insider bought in 180 days ($12M)
    GestorLens profile
  • Dexcom

    DXCM
    • 07:08 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 5% (18,917,265 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 16 concentrated managers (-2 this quarter)
    • 978 13F filers
    GestorLens profile
  • Hemab Therapeutics Holdings

    COAG
    • 07:08 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 results: loss per share of $0.58.

      Company headline: “Hemab Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update”

      From the company's release
      Net Loss: Net loss was $27.3 million, or $0.58 per share, for the three months ended September 30, 2026, compared to a net loss of $17.1 million, or $18.04 per share, for the three months ended September 30, 2025.

    On GestorLens

    • 5 concentrated managers (+4 this quarter)
    • 56 13F filers
    • 1 insider bought in 180 days ($2M)
    • 1 13D filings in the last year

    Well-known investors: Soros Fund

    GestorLens profile
  • Delek US Holdings

    DK
    • 07:07 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 6.3% (3,874,849 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 4 concentrated managers
    • 301 13F filers
    GestorLens profile
  • Dakota Gold

    DC
    • 07:06 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.3% stake (5,827,886 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 3 concentrated managers
    • 181 13F filers
    • 1 insider bought in 180 days ($100,358)
    GestorLens profile
  • Cullinan Therapeutics

    CGEM2 filings
    • 07:06 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 results.

      Company headline: “Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results”

      From the company's release
      Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results CLN-978 (CD19 TCE) multi-dose regimen data in SLE, RA, and Sjögren’s disease will be shared in December Velinotamig (BCMA TCE) data presented at ACR Convergence 2026; global Phase 1/2 study in autoimmune cytopenias initiated CLN-049 (FLT3 TCE) potentially registrational Phase 2 study in R/R AML underway…
    • 07:00 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4% stake (2,604,105 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 12 concentrated managers
    • 183 13F filers
    GestorLens profile
  • Sionna Therapeutics

    SION
    • 07:05 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 results.

      Company headline: “Sionna Therapeutics Reports Third Quarter 2026 Financial Results”

      From the company's release
      Implemented Workforce Reduction and Cost-Saving Measures: In September 2026, following a comprehensive review of its operations, Sionna implemented a workforce reduction of approximately 46% and other cost-saving measures to focus resources on advancing SION-451 + SION-2222 and extend its operating runway.

    On GestorLens

    • 11 concentrated managers (+3 this quarter)
    • 146 13F filers
    • 2 13D filings in the last year

    Well-known investors: Viking Global

    GestorLens profile
  • Olema Pharmaceuticals

    OLMA
    • 07:05 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 (ended September 30, 2026) results.

      Company headline: “Olema Oncology Reports Third Quarter 2026 Financial and Operating Results”

      From the company's release
      Cash, cash equivalents, and marketable securities as of September 30, 2026, were $413.8 million.

    On GestorLens

    • 10 concentrated managers (-2 this quarter)
    • 183 13F filers
    • 1 13D filings in the last year

    Well-known investors: Stanley Druckenmiller

    GestorLens profile
  • CytomX Therapeutics

    CTMX
    • 07:04 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.1% stake (9,025,855 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 5 concentrated managers
    • 178 13F filers
    GestorLens profile
  • Ovid Therapeutics

    OVID
    • 07:03 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Company headline: “Ovid Therapeutics Reports Business Updates and Third Quarter 2026 Financial Results”

      From the company's release
      Potential monetization of soticlestat interests: As previously announced, Ovid and Takeda assigned global rights in soticlestat to a new company launched by Perceptive Advisors.

    On GestorLens

    • 5 concentrated managers
    • 129 13F filers
    GestorLens profile
  • Cytokinetics

    CYTK
    • 07:03 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 5.1% (7,143,229 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 17 concentrated managers (-3 this quarter)
    • 482 13F filers
    GestorLens profile
  • Cummins

    CMI
    • 07:01 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports 5% (6,836,104 shares), 5% or less as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 19 concentrated managers (-1 this quarter)
    • 2,110 13F filers

    Well-known investors: Semper Augustus

    GestorLens profile
  • Opus Genetics

    IRD
    • 07:01 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 results.

      Company headline: “Opus Genetics Announces Financial Results for Third Quarter 2026 and Provides Corporate Update”

      From the company's release
      Opus Genetics Announces Financial Results for Third Quarter 2026 and Provides Corporate Update OPGx-BEST1 Cohort 2 Dosing Complete and Data Expected in Q1 2027 OPGx-LCA5 Registrational Phase 3 Trial Fully Enrolled with Initiation of Dosing Expected in Q4 2026 FDA Clearance of IND for OPGx-RDH12…

    On GestorLens

    • 4 concentrated managers
    • 103 13F filers
    • 1 13D filings in the last year
    GestorLens profile
  • D-Wave Quantum

    QBTS
    • 07:01 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 results: revenue of $4.5 million; loss per share of $0.13.

      Company headline: “D-Wave Reports Third Quarter 2026 Results”

      From the company's release
      Revenue for the third quarter of 2026 was $4.5 million, up 21% year over year.

    On GestorLens

    • 1 concentrated managers (+1 this quarter)
    • 557 13F filers
    GestorLens profile
  • BioNTech

    BNTX
    • 07:01 ETOtherSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “BioNTech to Acquire US FDA Priority Review Voucher”

      From the company's release
      BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that it has entered into an agreement to acquire a US Food and Drug Administration (“FDA”) Priority Review Voucher (“PRV”) from Scholar Rock, Inc. (Nasdaq: SRRK, “Scholar Rock”) for a total cash consideration of $205 million.

    On GestorLens

    • 11 concentrated managers (+2 this quarter)
    • 283 13F filers
    GestorLens profile
  • Enova International

    ENVA
    • 07:01 ETDividends and buybacksSEC 8-K 8.01

      Share buyback

      New share buyback of up to $500 million.

      Company headline: “ENOVA ANNOUNCES NEW $500 MILLION SHARE REPURCHASE PROGRAM”

      From the filing
      On November 10, 2026, Enova International, Inc. (the "Company") announced that its Board of Directors had authorized a share repurchase program for up to $500 million of the Company's outstanding common stock.

    On GestorLens

    • 3 concentrated managers
    • 429 13F filers
    GestorLens profile
  • Liquidia

    LQDA
    • 07:00 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 results.

      Also: Other events

      From the company's release
      October 2026, the daily referral rate was more than 75% of the daily referral rate for the third quarter.

    On GestorLens

    • 7 concentrated managers (-1 this quarter)
    • 336 13F filers
    • 1 insider bought in 180 days ($317,894)
    GestorLens profile
  • Janus International Group

    JBI
    • 07:00 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 results: revenue of $213.1 million; loss per share of $0.10.

      Company headline: “JANUS INTERNATIONAL GROUP REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS”

      Also: Regulation FD disclosure

      From the company's release
      Revenues of $213.1 million, down 2.8% year-over-year.

    On GestorLens

    • 3 concentrated managers (+1 this quarter)
    • 225 13F filers
    GestorLens profile
  • Cullen/Frost Bankers

    CFR
    • 06:59 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.7% stake (2,930,133 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 3 concentrated managers (-2 this quarter)
    • 569 13F filers
    GestorLens profile
  • Crispr Therapeutics

    CRSP
    • 06:58 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 5.2% (4,994,047 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 4 concentrated managers (+1 this quarter)
    • 522 13F filers
    GestorLens profile
  • Corvus Pharmaceuticals

    CRVS
    • 06:57 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4% stake (3,331,535 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 3 concentrated managers (-3 this quarter)
    • 172 13F filers
    • 2 insiders bought in 180 days ($333,654)
    • 2 13D filings in the last year
    GestorLens profile
  • Compass Therapeutics

    CMPX
    • 06:55 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.3% stake (7,737,938 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 5 concentrated managers (-6 this quarter)
    • 215 13F filers
    • 1 insider bought in 180 days ($21,250)
    GestorLens profile
  • Commerce Bancshares

    CBSH
    • 06:54 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.7% stake (6,739,385 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 2 concentrated managers
    • 508 13F filers
    GestorLens profile
  • Cogent Communications Holdings

    CCOI
    • 06:52 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 3.4% stake (1,756,368 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 6 concentrated managers (-1 this quarter)
    • 222 13F filers
    GestorLens profile
  • Cisco Systems

    CSCO
    • 06:51 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports 5% (196,095,068 shares), 5% or less as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 59 concentrated managers (+7 this quarter)
    • 4,103 13F filers

    Well-known investors: Markel Group

    GestorLens profile
  • GFL Environmental

    GFL
    • 06:50 ETOtherSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “GFL Environmental Concludes Review of Unsolicited Inbound Proposals; Board Unanimously Reaffirms Strategy to Remain Public”

      From the company's release
      GFL Environmental Inc. (NYSE: GFL) (TSX: GFL) (“GFL” or the “Company”) today confirmed that a Special Committee of the Board of Directors (the “Board”) has concluded its previously announced process to review unsolicited proposals to acquire the Company and take it private.

    On GestorLens

    • 6 concentrated managers (+2 this quarter)
    • 327 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • Carlisle Companies

    CSL
    • 06:49 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      Filed by: STATE STREET CORP

    On GestorLens

    • 11 concentrated managers
    • 797 13F filers
    GestorLens profile
  • Caredx

    CDNA
    • 06:48 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      Filed by: STATE STREET CORP

    On GestorLens

    • 5 concentrated managers
    • 229 13F filers
    GestorLens profile
  • Brightstar Lottery

    BRSL
    • 06:43 ETEarningsSEC 6-K

      Foreign issuer report

      Q3 2026 (ended September 30, 2026) results.

      Company headline: “BRIGHTSTAR LOTTERY PLC REPORTS THIRD QUARTER 2026 RESULTS”

      From the company's release
      Diluted net income per share and Adjusted EPS from continuing operations include $43 million ($0.23 per share) of Brightstar's portion, net of tax, of service revenue amortization compared to $23 million ($0.12 per share) in 2025.

    On GestorLens

    • 4 concentrated managers (+1 this quarter)
    • 198 13F filers
    GestorLens profile
  • Black Hills

    BKH
    • 06:43 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports 5% (3,806,682 shares), 5% or less as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 5 concentrated managers (+1 this quarter)
    • 477 13F filers
    GestorLens profile
  • Biogen

    BIIB
    • 06:42 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 5.1% (7,570,589 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 12 concentrated managers (-3 this quarter)
    • 1,046 13F filers
    GestorLens profile
  • Biocryst Pharmaceuticals

    BCRX
    • 06:38 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.8% stake (12,294,412 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 8 concentrated managers (-1 this quarter)
    • 318 13F filers
    GestorLens profile
  • Avery Dennison

    AVY
    • 06:37 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.7% stake (3,595,632 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 3 concentrated managers
    • 784 13F filers
    GestorLens profile
  • Avalo Therapeutics

    AVTX
    • 06:36 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.8% stake (2,563,226 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 15 concentrated managers (+3 this quarter)
    • 125 13F filers
    GestorLens profile
  • Automatic Data Processing

    ADP
    • 06:33 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.9% stake (19,605,453 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 43 concentrated managers
    • 2,299 13F filers

    Well-known investors: Giverny Capital, Terry Smith

    GestorLens profile
  • Atlantic Union Bankshares

    AUB
    • 06:33 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.9% stake (7,048,441 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 3 concentrated managers
    • 455 13F filers
    GestorLens profile
  • TransDigm Group

    TDG
    • 06:32 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Fiscal Q4 (ended September 30, 2026) results: revenue of $2.99 billion; EPS of $10.33 (adjusted: $12.44).

      Company headline: “TransDigm Group Reports Fiscal 2026 Fourth Quarter and Year-End Results”

      From the company's release
      Net sales of $2,988 million, up 23% from $2,437 million in the prior year's quarter;

    On GestorLens

    • 35 concentrated managers
    • 1,145 13F filers

    Well-known investors: Dan Loeb, Lone Pine

    GestorLens profile
  • Venture Global

    VG
    • 06:31 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 results.

      Company headline: “Venture Global Reports Third Quarter 2026 Results”

      From the company's release
      Increased Consolidated Adjusted EBITDA guidance to $10.0 - $10.3 billion1, up from $8.7 - $9.1 billion, which assumes a weighted average liquefaction fee of $21.00/MMBtu - $22.00/MMBtu for our remaining unsold cargos, in line with current forward curves.

    On GestorLens

    • 10 concentrated managers (+1 this quarter)
    • 376 13F filers
    • 1 insider bought in 180 days ($15,987)
    GestorLens profile
  • Astronics

    ATRO
    • 06:31 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 5.1% (1,840,896 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 3 concentrated managers (+1 this quarter)
    • 313 13F filers
    • 1 13D filings in the last year
    GestorLens profile
  • Associated Banc-Corp

    ASB
    • 06:30 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.4% stake (8,364,775 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 395 13F filers
    • 1 13D filings in the last year
    GestorLens profile
  • Arcutis Biotherapeutics

    ARQT
    • 06:29 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 6.1% (7,718,628 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 5 concentrated managers (-1 this quarter)
    • 273 13F filers
    GestorLens profile
  • Archer Aviation

    ACHR
    • 06:28 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.7% stake (36,379,249 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 2 concentrated managers
    • 527 13F filers
    • 1 13D filings in the last year
    GestorLens profile
  • Ameris Bancorp

    ABCB
    • 06:27 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.8% stake (3,210,262 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 3 concentrated managers
    • 389 13F filers
    GestorLens profile
  • Altimmune

    ALT
    • 06:26 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.3% stake (8,356,408 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 5 concentrated managers (+4 this quarter)
    • 210 13F filers
    • 1 insider bought in 180 days ($44,250)

    Well-known investors: Viking Global

    GestorLens profile
  • Allogene Therapeutics

    ALLO
    • 06:22 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.7% stake (16,326,197 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 5 concentrated managers (+2 this quarter)
    • 207 13F filers
    • 2 13D filings in the last year
    GestorLens profile
  • Allegion

    ALLE
    • 06:22 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.2% stake (3,581,089 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 11 concentrated managers (+3 this quarter)
    • 736 13F filers
    • 1 insider bought in 180 days ($26,908)
    GestorLens profile
  • Albemarle

    ALB
    • 06:21 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 5.4% (6,329,610 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 8 concentrated managers (+1 this quarter)
    • 947 13F filers
    GestorLens profile
  • ADMA Biologics

    ADMA
    • 06:20 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 6.1% (13,675,348 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 4 concentrated managers
    • 321 13F filers
    • 1 insider bought in 180 days ($150,749)

    Well-known investors: Stanley Druckenmiller, Terry Smith

    GestorLens profile
  • Accenture

    ACN
    • 06:18 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reported a stake: 5.5% (33,523,019 shares) (passive, 13G) as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 40 concentrated managers (-4 this quarter)
    • 1,915 13F filers
    • 2 insiders bought in 180 days ($3.2M)

    Well-known investors: Markel Group

    GestorLens profile
  • Acadia Pharmaceuticals

    ACAD
    • 06:17 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.4% stake (7,650,889 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 6 concentrated managers (-2 this quarter)
    • 351 13F filers
    • 1 13D filings in the last year
    GestorLens profile
  • Wix.com

    WIX
    • 06:17 ETEarningsSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “Wix Reports Third Quarter 2026 Results”

      From the company's release
      “We believe our strategic investments in Base44 are positioning us to capture share in a rapidly expanding market – with Base44 ARR today close to $250 million.

    On GestorLens

    • 3 concentrated managers (-3 this quarter)
    • 237 13F filers

    Well-known investors: ValueAct, Soros Fund

    GestorLens profile
  • Kanzhun

    BZ
    • 06:16 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Image Frame Investment (HK) and 1 related filer report a 2.2% stake (18,324,051 shares), below 5% as of September 30, 2026.

      Filed by: Tencent Holdings Ltd

    On GestorLens

    • 7 concentrated managers (+1 this quarter)
    • 252 13F filers
    GestorLens profile
  • 4D Molecular Therapeutics

    FDMT
    • 06:16 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      State Street reports a 4.5% stake (2,469,425 shares), below 5% as of September 30, 2026.

      Filed by: STATE STREET CORP

    On GestorLens

    • 6 concentrated managers
    • 156 13F filers
    GestorLens profile
  • Magnachip Semiconductor

    MX
    • 06:15 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Chae Lee (Chief Executive Officer) bought 70,000 shares for $155,360 (avg. $2.22).

    On GestorLens

    • 2 concentrated managers
    • 77 13F filers
    • 1 insider bought in 180 days ($318,600)
    • 1 13D filings in the last year

    Well-known investors: Howard Marks

    GestorLens profile
  • On Holding

    ONON
    • 06:06 ETEarningsSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “On Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2026”

      From the company's release
      On delivers record net sales and the highest gross profit margin in its history as it pursues its ambition to redefine what a sportswear brand can be. Third quarter net sales increase by 17.2% year-over-year, or by 17.8% on a constant currency basis, to CHF 931.4 million, surpassing CHF 900 million in a quarter for the first time, with every channel, region and category contributing strongly.

    On GestorLens

    • 12 concentrated managers (+2 this quarter)
    • 495 13F filers
    • 3 insiders bought in 180 days ($10.6M)

    Well-known investors: Lone Pine, Gates Foundation Trust

    GestorLens profile
  • Atour Lifestyle Holdings

    ATAT
    • 06:02 ETEarningsSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “Atour Lifestyle Holdings Limited Reports Third Quarter 2026…”

      From the company's release
      As of September 30, 2026, there were 2,288 hotels with a total of 254,800 hotel rooms in operation across Atour’s hotel network, representing increases of 17.5% and 16.2% year-over-year in terms of the number of hotels and hotel rooms, respectively.

    On GestorLens

    • 8 concentrated managers (-1 this quarter)
    • 179 13F filers
    GestorLens profile
  • WESCO International

    WCC
    • 06:00 ETOtherSEC 8-K 7.01

      Regulation FD disclosure

      Company headline: “Data Center Leadership: One Partner, Complete Lifecycle, Around the World November 10, 2026”

    On GestorLens

    • 10 concentrated managers
    • 708 13F filers
    • 1 insider bought in 180 days ($351,254)

    Well-known investors: Seth Klarman

    GestorLens profile

What each filing is

Form 8-K
The current report of a material event: the company has 4 business days to file it. Each item is a type of event; the label is the one the company chose.
Schedule 13D
Whoever crosses 5% of the shares intending to influence the company (board seats, a sale, a change of strategy) files a 13D within 5 business days. It is the typical activist filing. More in the glossary
Schedule 13G
The form filed by whoever crosses 5% of a company's shares as a passive investor, with no intent to influence it. Mostly filed by large asset managers and index funds. More in the glossary
Form 4
The form directors, officers and 10%+ shareholders use to report every purchase or sale of their own company's shares, within 2 business days. Only open-market purchases (code P) are shown here. More in the glossary
Form 144
The notice an insider or major shareholder files BEFORE selling restricted shares, when the sale exceeds 5,000 shares or $50,000 in three months. It states how many shares they plan to sell and from when: it does not confirm the sale happened (that comes later in a Form 4).

Everything comes from SEC EDGAR, the system where companies file their documents with the SEC.

Source: SEC EDGAR. Text is built with fixed rules from each filing, without artificial intelligence; quotes stay in their original language. Times are New York (ET), with your browser's time next to them.

Filings are grouped by the New York date and time at which the SEC received each document.

Not investment advice. A notice of proposed sale (Form 144) does not confirm that a sale took place.

Follow the investors you care about

Build your list and get what they report by email, if you turn it on. Free, no credit card.

Create free account